EXUMA Biotech Corp.
New Filing
CIK: 0001698021·Biotechnology·DELAWARE·Filed: Aug 20, 2026
Total Offering
$70,000,000
Amount Sold
$70,000,000
Investors
26
First Sale
May 26, 2026
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Gregory Frost | |
| David Ramsay | |
| Daniel Flynn | |
| Houston Holmes | |
| Frank McCormick | |
| Richard Yan |
Company
SEC Filing
0001698021-26-000003
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free